Opus Genetics Inc
(IRD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,940 | -4,692 | -3,088 | -6,169 | -6,767 |
| Depreciation Amortization | 7 | 383 | 5 | 3 | -55 |
| Accounts payable and accrued liabilities | 214 | 178 | 10 | -168 | N/A |
| Other Working Capital | 371 | 96 | -192 | 357 | 47 |
| Other Operating Activity | 2,909 | 2,652 | 2,533 | 2,384 | -1,790 |
| Operating Cash Flow | $-2,439 | $-1,383 | $-732 | $-3,593 | $-8,565 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 112 |
| PPE Investments | N/A | N/A | N/A | -25 | -14 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-25 | $99 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,748 | 771 | 448 | 4,706 | N/A |
| Common Stock Issued | N/A | N/A | N/A | N/A | 7,654 |
| Other Financing Activity | -124 | -71 | 0 | -2 | 0 |
| Financing Cash Flow | $1,624 | $700 | $448 | $4,704 | $7,654 |
| Beginning Cash Position | 1,537 | 1,537 | 1,537 | 451 | 8,744 |
| End Cash Position | 722 | 854 | 1,253 | 1,537 | 7,932 |
| Net Cash Flow | $-815 | $-683 | $-284 | $1,086 | $-812 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,439 | -1,383 | -732 | -3,593 | -8,565 |
| Capital Expenditure | N/A | N/A | N/A | -25 | -19 |
| Free Cash Flow | -2,439 | -1,383 | -732 | -3,618 | -8,584 |